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ABSTRACT The interaction of an antimicrobial peptide, MSI-78, with phospholipid bilayers has been investigated using atomic
force microscopy, circular dichroism, and nuclear magnetic resonance (NMR). Binding of amphipathic peptide helices with their
helical axis parallel to the membrane surface leads to membrane thinning. Atomic force microscopy of supported 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) bilayers in the presence of MSI-78 provides images of the membrane thinning
process at a high spatial resolution. This data reveals that the membrane thickness is not reduced uniformly over the entire
bilayer area. Instead, peptide binding leads to the formation of distinct domains where the bilayer thickness is reduced by 1.1 6
0.2 nm. The data is interpreted using a previously published geometric model for the structure of the peptide-lipid domains. In
this model, the peptides reside at the hydrophilic-hydrophobic boundary in the lipid headgroup region, which leads to an in-
creased distance between lipid headgroups. This picture is consistent with concentration-dependent 31P and 2H NMR spectra
of MSI-78 in mechanically aligned DMPC bilayers. Furthermore, 2H NMR experiments on DMPC-d54 multilamellar vesicles
indicate that the acyl chains of DMPC are highly disordered in the presence of the peptide as is to be expected for the proposed
structure of the peptide-lipid assembly.
INTRODUCTION
Antimicrobial peptides are important components of the
defense mechanism of animals and plants against pathogens
(1). The most abundant form of antimicrobial peptide is the
linear peptide. Two common properties, cationic and amphi-
pathic structure, are thought to enable them to permeabilize
microbial membranes selectively.
Magainins (magainin 2 and PGLa) are well-studied linear
antimicrobial peptides that were originally isolated from the
skin of the African frog Xenopus laevis (2,3). To increase the
antimicrobial activity and selectivity, several synthetic pep-
tides designed based on the naturally occurring magainin 2
and PGLa peptides have been reported (3). One of the most
potent peptides, MSI-78 (amino-acid sequence G-I-G-K-F-
L-K-K-A-K-K-F-G-K-A-F-V-K-I-L-K-K-NH2, also known
as pexiganan), is an analog of magainin 2. This peptide has
been the focus of pharmaceutical development largely be-
cause of the relative safety of topical therapy and the un-
certainty surrounding the long-term toxicology of any new
class of drug administered systemically. Previous nuclear
magnetic resonance (NMR) studies analyzed the interaction
of MSI-78 with various lipid bilayers and revealed the
peptide-induced changes in the lipid headgroup conforma-
tion (4). The data showed that MSI-78 induces positive cur-
vature strain on lipid bilayers and also predicted toroidal pore
formation at higher concentrations (;10 mol % of peptide),
which is consistent with ﬂuorescence studies on magainin 2.
To better understand the mechanism of peptide-lipid
interaction, the present study uses atomic force microscopy
(AFM), NMR, and circular dichroism (CD) to investigate the
interaction of MSI-78 with 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) and 1-palmitoyl-2-oleoyl-sn-glyc-
ero-3-phosphocholine (POPC) lipid bilayers. DMPC and
POPC lipid bilayers are commonly used for many biophys-
ical studies reported in the literature. The gel-to-liquid-crys-
talline phase-transition temperatures of these lipids are suitable
for CD, NMR, and AFM experiments. Our previous NMR
studies also used these lipids (4), the results of which are
useful to make comparison with the data reported in this
study. DMPC was selected for use in the AFM experiments
to allow comparison with the NMR experiments because it
forms a ﬂuid-phase supported lipid bilayer at the temperatures
employed.
In particular, during AFM experiments, peptide-induced
changes in lipid membranes were observed at high lateral
resolution (;10 nm), whereas time-lapse series of images
provided information about the dynamics of the process. The
resulting data can be interpreted using a simple geometrical
model for the peptide-lipid assemblies. The peptide-induced
membrane-thinning effect observed by AFM is in excellent
agreement with the peptide-induced disorder in the acyl re-
gions of the lipid bilayer measured using 2H NMR experi-
ments.
The mechanism for peptide-induced membrane disruption
has been the topic of many previous studies. At low peptide/
lipid (P/L) ratios, amphipathic helical segments of these
peptides are adsorbed onto lipid bilayers with the helical axis
parallel to the membrane surface (5,6). Above a certain crit-
ical concentration (P/L*), the peptides disrupt membranes
via one of the well-studied mechanisms such as barrel-stave,
toroidal pore formation, detergent-type micellization, and
induction of nonlamellar phases (1,4–12). Toroidal-pore
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formation has been well characterized using ﬂuorescence
(10) and NMR (4,11) studies. Neutron diffraction experi-
ments have also been valuable in the analysis of these peptide
assemblies in lipidmembranes (5,8,9,13,14). Interestingly, be-
fore the onset of cytolytic activity, peptide-membrane inter-
action leads to thinning of the membrane in proportion to the
peptide concentration (6,15).
At present, the literature offers little information about the
spatial distribution of peptides during membrane thinning.
Past investigations generally reported the thicknesses aver-
aged over a micrometer or millimeter range. Recently, the
group of de Kruijff has used AFM in addition to NMR and
differential scanning calorimetry to investigate the structure
of different classes of antimicrobial peptides associated with
gel-state lipid bilayers (16–18). In the present study, time-
lapse scanning-probe imaging provides high resolution visual-
ization of the peptide-membrane interaction. This technique
allows the direct measurement of local membrane thickness
rather than average properties. The experimental data reveals
that the peptide does not induce uniform membrane thinning,
but instead leads to the formation of distinct domains in the
lipid bilayer.
EXPERIMENTAL PROCEDURES
The MSI-78 peptide sample was originally designed and synthesized by
Genaera (Philadelphia, PA). The 15N-Phe16-labeledMSI-78 was synthesized
and puriﬁed at the University of Michigan using the published procedure (3).
For AFM experiments, a stock solution of concentration 1 mg/ml in Tris
buffer was diluted with deionized water for a ﬁnal concentration between 10
and 100 mg/ml (4–40 mM). Lipids, 1,2-dimyristoyl-sn-glycero-3-phospho-
choline (DMPC), DMPC-d4 and DMPC-d54, and 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) were purchased from Avanti Polar Lipids
(Alabaster, AL). Chloroform and methanol were procured from Aldrich
Chemical (Milwaukee, WI), and naphthalene was from Fisher Scientiﬁc
(Pittsburgh, PA). All the chemicals were used without further puriﬁcation.
Atomic force microscopy (AFM)
Several milligrams of DMPC powder were dissolved in chloroform in a 10-
ml round-bottom ﬂask and the solvent was evaporated under vacuum to form
a thin lipid ﬁlm on the glass wall. The lipids were then hydrated for up to 30
min with 20 mM NaCl in a water bath above the main phase-transition
temperature of the lipids (24C for DMPC). To completely suspend the lipid
ﬁlm in the salt solution, the sample was placed in a heated bath sonicator for
a few minutes. The milky lipid suspension was then sonicated three times for
5 min using a CZ261 Sonic andMaterials Vibra-Cell probe sonicator (Sonics
& Materials, Danbury, CT). This procedure resulted in a clear suspension of
small unilamellar vesicles (SUVs). Metal particles introduced by the son-
icator tip were removed by centrifugation. The SUV solution was diluted
with NaCl solution if necessary. Typical concentrations used to prepare
bilayer samples for AFM were 0.25–1 mg/ml.
Supported lipid bilayers were formed on pieces of freshly cleaved mica
by vesicle fusion. The substrates, 1 cm3 1 cm mica sheets, were attached to
metal sample pucks by double-sided tape. After placing a 60–80 ml drop of
liposome solution on the mica, the sample was incubated in a closed con-
tainer for 20–60 min. Samples were then gently rinsed with deionized water
and transferred to the AFM for imaging. During AFM scanning, the sample
temperature was 28C, which is above the main phase-transition temperature
for DMPC, i.e., the lipid bilayers were in the liquid crystalline state (19).
All AFM images were obtained on a Multimode AFM (Veeco Me-
trology, Santa Barbara, CA) in tapping mode in aqueous solution at pH 6
using a standard silicon nitride cantilever as described previously (20,21).
Typical scan sizes were 1 mm at a resolution of 256 3 256 data points and
a scan rate of 2.5–3 Hz. One image was therefore acquired in 1.5–2 min.
Bilayer samples were inspected by AFM, and a smooth region with few or
no defects was chosen. The AFM tip was then retracted to add 20–30 ml of
MSI-78 solution to the sample volume using a syringe needle. The resulting
total peptide concentration was between 1 and 10 mM. Imaging continued
for up to 1 h to observe the effect of the peptide on the lipid bilayer.
For determining the relative thicknesses of peptide-perturbed and un-
perturbed bilayer, only depressions wide enough to show the ﬂat part of the
P-phase were considered. A zoom box was placed across a step between the
higher and the lower level. A histogram of the height distribution within this
area then has two clearly distinguishable peaks. The distance between the
peak maxima is the average relative height change between the two phases.
This procedure was repeated for several areas of ﬁve different samples. The
resulting average change in thickness was 1.1 6 0.2 nm.
Circular dichroism (CD)
SUVs were prepared using the following procedure. 10 mM Tris buffer (150
mMNaCl and 0.1 mM EDTA, pH 7.4) was added to a dry ﬁlm of POPC and
subjected to vortex and sonication to obtain a clear dispersion of SUVs. A
40-mM peptide stock solution was prepared in Tris buffer. CD spectra were
recorded on an AVIV CD spectropolarimeter (Lakewood, NJ) using samples
with peptide/lipid ratios 1:100 and 1:200 over the range from 200 to 250 nm
at 25C. A 5-mm quartz cuvette was used for measurements. Signal from
SUVs and the buffer were removed by subtracting the spectra of corre-
sponding control samples without peptide.
Preparation of samples for NMR measurements
Mechanically aligned DMPC bilayer samples for NMR experiments were
prepared using the recently published naphthalene procedure (7). Brieﬂy,
four milligrams of lipids for 31P and 2H NMR and 100 milligrams of lipids
for 15N NMR and an appropriate amount (since the P:L molar ratios are
presented in the article, one can calculate the exact quantity of the peptide
used in each experiment) of MSI-78 were dissolved in CHCl3/CH3OH (2:1)
mixture containing equimolar amounts of naphthalene. The solution was
spread on thin glass plates (11 mm 3 22 mm 3 50 mm, Paul Marienfeld,
Bad Mergentheim, Germany) and then dried under N2 gas at room
temperature. The lipid ﬁlms were then dried under vacuum at;35C for;8
h to remove naphthalene and any residual organic solvents. The glass plates
were placed in a hydration chamber that was maintained at ;93% relative
humidity for 2–3 days at 37C. Approximately 2–5 mL of deionized water
was sprayed onto the surface of the lipid-peptide ﬁlm on glass plates. The
glass plates were stacked, wrapped with paraﬁlm, sealed in plastic bags
(Plastic Bagmart, Marietta, GA), and then incubated at 4C for 6–24 h.
Multilamellar vesicles (MLVs) for 2H NMR experiments were prepared
as follows. Approximately 5.0 mg of lipid and the desired amount of peptide
were dissolved in CHCl3/CH3OH (2:1) mixture. The solvent was removed
under N2 and the lipid-peptide mixture was dried under vacuum overnight.
Approximately 55 wt % deuterium-depleted water (Aldrich, Milwaukee,
WI) was added and the mixture was subjected to several cycles of freeze-
thaw with a gentle vortex to produce MLVs of DMPC.
Solid-state NMR
All experiments were performed on a Chemagnetics/Varian Inﬁnity 400
MHz solid-state NMR spectrometer (Chemagnetics, Varian, Palo Alto, CA)
operating with resonance frequencies of 400.138, 161.979, 61.424, and
40.55 MHz for 1H, 31P, 2H, and 15N nuclei, respectively. A Chemagnetics
temperature-controller unit was used to maintain the sample temperature,
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and the sample was equilibrated for at least 30 min before starting each
experiment. All experiments on oriented samples were performed with the
bilayer-normal parallel to the external magnetic ﬁeld. The 31P spectra of
mechanically aligned samples were obtained using a homebuilt double-
resonance probe, which has a four-turn square coil (12 mm 3 12 mm 3 4
mm) constructed using a 2-mm-wide ﬂat-wire with a spacing of 1 mm be-
tween turns. 31P and 2H spectra of MLVs were obtained using a
Chemagnetics double-resonance probe. A typical 31P 90-pulse length of
3.1 ms was used in both probes. 31P chemical shift spectra were obtained
using a spin-echo sequence (90-t-180-t-acquire), 30 kHz proton-de-
coupling radio frequency ﬁeld, 50 kHz spectral width, and a recycle delay of
5 s. A typical spectrum required the co-addition of 100–500 transients. The
31P chemical shift spectra were referenced relative to 85% H3PO4 on thin
glass plates (0 ppm). 2H quadrupole coupling spectra were obtained using
a quadrupole-echo sequence (90-t-90-t-acquire) with a 90-pulse length
of 3.0 ms, a spectral width of 100 kHz, and a recycle delay of 2 s. A typical
spectrum required the co-addition of ;10,000 transients. Data processing
was accomplished using the software Spinsight (Chemagnetics/Varian) on a
Sun SPARC workstation (Sun Microsystems, Palo Alto, CA). Spectral
simulation for the 31P spectra was done using a FORTRAN program. The 2H
spectra of DMPC-d54 multilamellar dispersions were processed and de-
Paked using MatLab software (The MathWorks, Cambridge, MA) as ex-
plained in the literature (22). The 15N chemical shift spectrum was obtained
using a ramp cross-polarization (CP) sequence with a 1H p/2 pulse length of
3.5 ms, 35 kHz CP power, and a 1H decoupling of 71 kHz during acquisition.
Other experimental parameters include: 2000 scans, 3-s recycle delay, 50
kHz spectral width, and 1.25 ms ramp CP with a 10 kHz ramp on the 1H
channel. The 15N chemical shift spectrum was referenced to 15N labeled
ammonium sulfate powder at 24.1 ppm relative to liquid ammonia.
RESULTS
To understand the nature of interaction between MSI-78 and
lipid membranes, we examined the secondary structure of
MSI-78 in Tris buffer (pH ¼ 7.4) and in the presence of
POPC SUVs. The CD spectrum of MSI-78 in aqueous buffer
(Fig. 1 A) resembled the one for an unordered structure. How-
ever, in the presence of POPC vesicles, the peptide showed
two negative minima at ;207 and 222 nm (Fig. 1 B) sug-
gesting that the peptide folds into an a-helix upon binding to
the lipid membrane. The helical wheel projection in Fig. 1 C
shows an amphipathic helical structure of the peptide.
The adsorption of peptide helices to supported DMPC bi-
layers was observed using AFM. Fig. 2, A–C, shows typical
images of different bilayer samples at three different stages
of peptide coverage. Initially, the lipid bilayer that contains
no peptide was defect-free. After the addition of MSI-78, we
did not observe a uniform distribution of peptide binding to
the lipid membrane. Instead, within the ﬁrst 2 min, channel-
like depressions began to form in the bilayer, which are seen
as dark lines in Figs. 2 and 3. This system of channels grew
rapidly in size resulting in a network appearance of this
peptide-lipid phase (Fig. 3), which we will refer to as P-
phase. Once the P-phase was formed, the shape of the
domain boundaries remained ﬁxed for the duration of the
entire experiment, up to 1 h.
The depth of depressions was less than the fully hydrated
lipid bilayer thickness which is ;5 nm (19,23,24) (Fig. 2,
A–C). The smallest visible sites of peptide binding were
circular dimples with a diameter of ;25 6 4 nm as seen in
Fig. 2 A. Within 15–30 min after the addition of the peptide
to the lipid bilayer, some of the wider depressions could be
seen to have a ﬂat bottom (Fig. 2 B). Eventually, after 50–60
min, the P-phase covered most of the substrate (Fig. 2 C)
leaving only isolated plateau regions of the original bilayer.
The line scans of images in Fig. 2, B and C, reveal that the
P-phase had a well-deﬁned thickness that remained constant
independent of the total peptide coverage of the bilayer.
(Note that the actual depth can only be determined if the
width of the depression is .25–40 nm, considering the size
of the AFM tip given by the manufacturer.)
The average relative height difference between the two
phases was determined to be 1.1 6 0.2 nm by plotting a
histogram of the height distribution within several images of
ﬁve different samples. For this analysis, only ﬂat plateaulike
regions were chosen so as to avoid the problem of the ﬁnite
tip radius (i.e., small dimples as in Fig. 2 A were excluded).
Generally, the thickness of supported lipid bilayers can be
determined by measuring the step height from substrate to
top of bilayer in bilayer defect regions. By monitoring this
FIGURE 1 Circular dichroism spectra of MSI-78 in (A) Tris-buffer
(10 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, pH ¼ 7.4) and (B) 2 mM
POPC in Tris buffer. Peptide concentration was 20 mM and P/L was 1:100.
The mean helix contents of vesicle bound MSI-78 as calculated from the
mean residual ellipticity value at l222 nm are;45%. (C) Helical wheel pro-
jection of MSI-78.
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depth before and after the addition of MSI-78 it was con-
ﬁrmed that the bilayer thickness outside of the P-phase regions
was not affected by the peptide (data not shown).
A proton decoupled 15N chemical shift spectrum of
mechanically aligned POPC bilayers containing 3 mol %
15N-Phe16 labeled MSI-78 is given in Fig. 4. This spectrum
contains a single peak at 86 ppm that corresponds to the per-
pendicular edge of an unaligned 15N chemical shift aniso-
tropy spectrum. Since the peptide forms a helical structure on
lipid bilayers, the 15N data can be interpreted in terms of the
orientation of the peptide on the bilayer. Based upon pre-
viously reported structural studies on membrane-associated
peptides using solid-state NMR (25) this data reveals that the
helical MSI-78 is oriented along the bilayer surface, which
is perpendicular to the bilayer normal.
To measure any changes in the conformation of the lipid
headgroup due to MSI-78-lipid interactions, 31P and 2H
NMR experiments on mechanically aligned DMPC-d4 bi-
layers were carried out (Fig. 5). A single line;30 ppm in the
31P spectra (Fig. 5 A) indicates that the bilayers are aligned
and there are no nonlamellar phases due to the presence of
MSI-78 in the sample. However, the addition of MSI-78 de-
creases the chemical shift frequency value of the single peak
in a concentration-dependent manner. The presence of the
peptide decreases the 2H quadrupole splitting at the Ca site,
whereas it increases the 2H quadrupole splitting at the Cb site
(Fig. 5 B). A low intense broad line in 31P spectra (Fig. 5 A)
is due to the signal from the unoriented component of the
sample which is also marked in Fig. 5 B. The changes in the
31P and 2H spectra are discussed below.
Deuterium NMR experiments were performed on multi-
lamellar vesicles of DMPC-d54 to measure the peptide-
induced disorder in the acyl region of the bilayer. Deuterium
spectra of unoriented bilayers (data not shown) are de-Paked
to obtain aligned spectra of bilayers as explained elsewhere
(22). The de-Paked 2H NMR spectra are given in Fig. 6 A.
Deuterium quadrupolar couplings were measured from the
de-Paked spectra and the order parameters were calculated
using published procedures (22). The order parameter for
each carbon site of the lipid SN1 acyl chain is given in Fig. 6
B for DMPC with 1 mol % and without MSI-78. Order pa-
rameters for the other acyl chain (SN2) of DMPC are not
shown as they are similar to that of SN1. The order parameter
decreases with the increase of the carbon number as the
lower order acyl chain is highly disordered even for the pure
lipid bilayer (Fig. 6 B). However, the addition of MSI-78
decreases the order parameter for all carbon sites except the
terminal carbons (C14) of the acyl chain that are highly
disordered even in the absence of the peptide. This peptide-
induced disorder in the hydrophobic region of DMPC
bilayers is discussed below.
DISCUSSION
Previous studies have shown that membrane thinning is an
intermediate process that is crucial in the overall antimicro-
bial activity of the peptide (6,15,26). The AFM results pre-
sented here lead to new insights about the membrane
thinning effect of antimicrobial peptides. Huang et al., have
shown that helical peptides initially bind electrostatically
FIGURE 2 Representative AFM
height images and corresponding line
scans of DMPC bilayer at (A) ;10%
coverage, (B) ;30% coverage, and (C)
;70% coverage with MSI-78. The
amount of peptide coverage increased
over time. At the peptide concentrations
used, 70% coverage was obtained
within ;45 min. White lines indicate
the positions of the line scans.
FIGURE 3 AFM height images of DMPC
bilayer before and after adding MSI-78. Total
peptide concentration ;2 mg/ml ¼ 0.8 mM.
Scan size: 1 mm. (A) Pure ﬂuid DMPC
bilayers have a smooth surface and are stable
without changes for hours, (B) 3 min after
adding peptide, and (C) 8 min after adding
peptide.
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with the helical axes parallel to the bilayer surface at low
concentrations (6,15,26). Since MSI-78 forms an amphi-
pathic a-helical structure in lipid bilayers as shown by the
CD data (Fig. 1 A), it is likely that the hydrophobic part of the
helix (see Fig. 1 C) is exposed to the hydrophobic part of
the bilayer with the hydrophilic face of the helix interacting
with the lipid headgroup in the water phase. This in-plane
orientation of peptides in model lipid membranes has been
shown for several other antimicrobial peptides using 31P and
15N solid-state NMR experiments and has been conﬁrmed
for the case of MSI-78 (Fig. 4) (11,25). This model is sup-
ported by the previously reported 31P NMR results that
suggested the tilt of lipids in the presence of MSI-78. It is
further conﬁrmed by the 31P and 2H NMR experiments on
mechanically aligned DMPC-d4 bilayers (Fig. 5) as dis-
cussed below. The decrease in the frequency of the 31P peak
in Fig. 5 A suggests that the lipid is either tilted and/or the
headgroup conformation is altered by the presence of the
peptide. The addition of MSI-78 to DMPC-d4 bilayers de-
creases quadrupole coupling at the Ca site, while it increases
at the Cb site (Fig. 5 B). These changes can be interpreted in
terms of modulation of headgroup conformation and/or
dynamics. Since any changes in the dynamics of the lipid
headgroup (alteration of order or disorder or angular ﬂuc-
tuations) would have the same effect on both the carbon
sites, they would cause the quadrupole splittings to change in
the same direction for the a- and b-segments. The observed
counter-directional changes in the quadrupole splittings
cannot therefore be explained by the changes due to
dynamics of the headgroup. On the other hand, these results
can be interpreted in terms of a conformational change in the
phosphocholine headgroup of DMPC. NMR studies have
shown that the orientation of the P-N1 dipole of the
phosphocholine headgroup that is almost parallel to the plane
of the bilayer surface can be altered in the presence of electric
charges. For example, the addition of a cationic amphiphile
moves the N1 end of the dipole toward the water phase,
whereas an anionic amphiphile has the opposite effect (27).
Since MSI-78 is a cationic peptide at neutral pH, it could
repel the N1 end of the P-N1 dipole and move the dipole
toward the water phase of the bilayer, thus changing the
phosphocholine conformation. This interpretation is in good
agreement with the results reported for the effects of cations
(27) and a cationic peptide pardaxin (28) on the conforma-
tion of the lipid headgroup. Although the interaction of
pardaxin with the DMPC headgroup is similar to that of
MSI-78, the membrane disruptive mechanism of pardaxin
varied with membrane composition (7,28). In addition, the
observed NMR results are in excellent agreement with a re-
cent molecular dynamics study that showed hydrogen bond-
ing between positively charged amino acid residues (arginine
and lysine) of MSI-78 and the oxygens of the POPC head-
group regions (29). These results are in complete agreement
with a model where MSI-78 lies on the bilayer surface.
The Huang group has used the following geometric model
to describe these peptide-induced changes in the lipid head-
group region and the resulting membrane thinning effect of
antimicrobial peptides (6,15,26), (see also Fig. 7, A and B).
In the unperturbed bilayer the lipid chains of each molecule
occupy a volume v¼ Ad, where d is the average length of the
lipid chains and A the average area available in the plane of
the bilayer. Since the peptide helices push apart the lipid
headgroups, the cross sectional area to ﬁll by the tails
FIGURE 4 Nitrogen-15 chemical shift spectrum of mechanically aligned
POPC bilayers containing 3 mol % MSI-78 obtained at 30C.
FIGURE 5 31P (A) and 2H (B) NMR spectra of mechanically aligned
DMPC-d4 bilayers containing 0, 1, 3, and 5 mol % MSI-78. Signal from
unoriented component of the sample is marked by an asterisk.
FIGURE 6 (A) De-Paked 2H NMR spectra of DMPCMLVs containing 0,
1, and 3 mol % MSI-78. (B) Order parameters (SCD) of the SN1 acyl chain
for pure DMPC (rectangles) and bilayers containing 1 mol % MSI-78 (solid
circles). Order parameters of SN2 are similar to that of SN1 and for clarity
are not shown.
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increases by an amount cDA. Here c is the peptide/lipid ratio
in the top monolayer, and DA is the cross-sectional area along
the axis of the peptide helix (note that we are ignoring the
bottommonolayer for the moment; therefore c and P/L are not
the same). For a constant density (and therefore constant
volume) of the acyl chain region, its thickness is reduced ac-
cordingly by an amount Dd. This conservation of volume can
be written as Ad ¼ (A1cDA)(d–Dd). The expected height
change Dd is thus
Dd ¼ cDA
A1 cDA
d: (1)
AFM allows direct visualization of the peptide adsorption
process at high resolution. In this manner, we are able to
obtain information at length scales of only several nm rather
than measuring average properties. The data reveals that
peptide-membrane interaction does not lead to a gradual and
uniform thinning of the membrane. Instead, it is observed
that the peptide forms distinct domains of a peptide-lipid
phase within the lipid bilayer that has a well-deﬁned thick-
ness independent of the total amount of peptide bound to the
membrane. As P/L increases, so does the area covered by this
P-phase. As a result, the average thickness of the bilayer de-
creases linearly as a function of area covered by the P-phase.
The AFM experiments are therefore consistent with previous
data on magainin 2 peptide (15).
To estimate c in the P-phase, we can apply Eq. 1 using d¼
1.3 nm for the thickness of a DMPC hydrocarbon monolayer
and A ¼ 60 A˚2 (30–32). Furthermore, a 22-amino acid
peptide helix is expected to be 3.3-nm long (1.5 A˚ per
residue) and 1.1-nm wide (assuming it has similar dimen-
sions to alamethicin (33,34)), which gives DA¼ 360 A˚2. The
resulting change in membrane thickness is Dd # 1.1 nm,
even if c was as high as 1:1. (Given the relative cross-
sectional area of peptide and lipid, c is most likely ,1:1.)
This is in the range of experimentally determined Dd ¼ 1.1
6 0.2 nm. Another hypothetical structure of the P-phase is
shown in Fig. 7 C. In this model the peptide molecules
displace all lipid molecules within a region of the bilayer.
The resulting change in membrane thickness is 1.1 nm, given
a headgroup thickness of 0.9 nm (32,35) and assuming the
bottom monolayer is not affected. The above analysis in-
dicates that within the P-phase the molecules arrange as in
Fig. 7 B with c close to 1, or the structure resembles that
shown in Fig. 7 C. However, the AFM data does not allow us
to rule out the case of either Fig. 7 B or Fig. 7 C.
This information can be used to compare the AFM data to
the literature (15). In the following paragraphs it will be as-
sumed that all peptides are located in the top monolayer. The
total number of lipids obviously includes both the lipids
between peptide helices in the top monolayer as well as the
lipids in the bottom monolayer. In each case one lipid is
assumed to occupy an area of 60 A˚2, i.e., one-sixth that of the
peptide helix. The relationship between c and P/L is then c¼
(2 P/L)/(1–6 P/L). With this, Eq. 1 gives Dd as a function of
P/L, see the solid line in Fig. 8. The corresponding lipid layer
thickness including the lipid headgroup is shown as a dashed
line. This is the same analysis as in Fig. 8 of Ludtke et al.
(15) and is in good agreement with that data. For this
analysis, it makes no difference if the peptide is distributed
uniformly over the entire area or concentrated in certain
domains as the AFM images show. For comparison, the
dotted line in Fig. 8 is the theoretical average monolayer
thickness assuming the P-phase structure has the form of Fig.
7 C with a Dd of 1.1 nm. For example, if P/L ¼ 0.056 then
the ratio of P-phase to non-P-phase would be 50%, giving an
average monolayer thickness of 1.65 nm and an average
Dd of 0.55 nm. Fig. 8 shows that both our AFM data and Fig.
8 of Ludtke et al. (15) are in agreement with regard to
average membrane thickness.
For each of the AFM images shown in Figs. 2 and 3, the
fraction of the area covered by the P-phase can be deter-
mined using the bearing analysis of the NanoScope software
(Veeco Metrology). Using this and either model in Fig. 7 B
or Fig. 7 C, we can then estimate P/L in each image. Values
FIGURE 7 Schematic representation of membrane thinning effect.
(Shaded circles, cross section of peptide helix with its axis perpendicular
to this plane; open circles, DMPC headgroups; lipid tails are shown as lines.)
(A) Unperturbed lipid bilayer; (B) peptide helices push apart lipid
headgroups leading to greater mobility of lipid chains and membrane
thinning; and (C) top monolayer has been replaced by peptide layer. The
value Dd is the height difference measured by AFM.
FIGURE 8 Height change Dd (solid line) according to Eq. 1 and cor-
responding DMPC monolayer thickness (dashed line). Monolayer thickness
calculated by averaging the thickness of a DMPC monolayer with distinct
domains of pure peptide as in Fig. 7 C (dotted line).
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for P/L in Fig. 2, A and B, and Fig. 3, B and C, range from
0.006 to 0.028. This is probably below the threshold
concentration P/L* for peptide insertion (see Introduction).
For magainin in DMPC/DMPG bilayers, this threshold was
determined to be close to P/L ¼ 0.033 (36), but the exact
ratio depends both on peptide and lipid composition. Given
the coverage in Fig. 2 C, P/L¼ 0.06 for the model in Fig. 7 B
and P/L ¼ 0.09 for the model in Fig. 7 C. Thus the sample in
Fig. 2 C is probably close to or above the insertion limit. We
do caution the reader that these estimates based on P/L* are
very uncertain, since they are derived from values obtained
for magainin in a mixed DMPC/DMPG bilayer, whereas we
are a studying MSI-78 interacting with a pure DMPC bilayer.
However, we include the estimates because they may help
to provide comparison points with previously published
studies.
Using the known amount of peptide added to the sample
and the approximate area covered by the bilayer, we can put
an upper limit on P/L in the AFM sample volume; this
number is ;0.5. Note, however, that the entire amount of
peptide will not ﬁnd its way to the lipid bilayer. A certain
fraction will be lost to adsorption to other surfaces such as
the syringe, tip holder, and cantilever. As shown above, even
if most of the peptide eventually diffuses toward the bilayer,
at least in the early stages of the experiment P/L will be
below the insertion limit. We are therefore conﬁdent that the
changes seen in Fig. 3, B and C, and Fig. 2, A and B, are
formed by peptides oriented parallel to the membrane plane
as expected for concentrations below P/L*.
If the peptide causes membrane thinning as shown in Fig.
7 B, the acyl chains of the lipids should be highly disordered
in the presence of the peptide. To conﬁrm this effect, 2H
NMR experiments were performed on DMPC-d54 lipid bi-
layers, and order parameters were measured (Fig. 6). As seen
from Fig. 6 B, the acyl chains of DMPC are highly disor-
dered in the presence of the peptide. Since the helical peptide
interacts with the headgroup region, as seen from previous
31P solid-state NMR results from POPC bilayers (4), as well
as from the 31P and 2H data given in Fig. 5, the acyl chains
have more free-area to explore as shown in Fig. 7 B and,
therefore, they are more disordered in the presence of the
peptide. These results are in excellent agreement with a recent
molecular dynamics simulation study on POPC bilayers
containing helical MSI-78 peptides (29). This effect has also
been reported for another amphipathic a-helical antimicro-
bial peptide, LL37 (22). Interestingly, studies have shown
that the peptide-induced disorder is similar to the increase in
the temperature of the sample that also causes membrane
thinning (22). Therefore, the NMR data is in agreement with
the model in Fig. 7 B and rules out the possibility given in
Fig. 7 C, since it would not decrease the order parameter of
the acyl chain, but instead would increase the order param-
eter at least for the lower end of the acyl chain. The NMR
data supporting model in Fig. 7 B provides the key support
for our assumption that the limit on c is ;1. This can be
understood as follows. In the derivation of Eq. 1, the hydro-
carbon region of the lipid bilayer is treated as a continuous
ﬂuid that ﬁlls the space between the lipid headgroup/peptide
region and the bottom lipid layer. In reality, however, the
hydrocarbon region consists of two lipid tails per headgroup
of ﬁnite length and width. The model therefore breaks down
once Dd approaches 1.3 nm. At this point the structure will
look more like that shown in Fig. 7 C. To apply Eq. 1 to our
data, the lipid tails have to be able to ﬁll the space underneath
the area covered by lipid headgroups and the peptide helices.
Without trying to set a rigorous limit on the value of c, the
relative dimensions of lipid tails and peptide helix point to it
being close to 1 (two hydrocarbon chains of 1.3-nm length
and one a-helix of 3.3 nm 3 1.1 nm). With more than one
peptide per lipid there will be ‘‘empty spaces’’ below the
peptide helices, resulting in a structure (Fig. 7 C) that is in-
consistent with our NMR data.
It should be noted that the peptide concentrations (1 or 3
mol %) used in NMR samples are not sufﬁcient to perturb all
of the lipids in the sample. Therefore, NMR samples should
contain peptide-free (or unperturbed) and peptide-rich (or
perturbed) domains, but the lipids must be under fast ex-
change during the NMR timescale to result in an average 2H
quadrupole coupling as observed by a single Pake doublet
for each CD2 group in the
2H spectra (or a single 31P peak in
a mechanically aligned sample as shown in Fig. 5 A). This is
unlike the AFM data that provides the evidence for the pres-
ence of two different domains in the supported bilayer sam-
ple. We also would like to point out that whereas the P/L
used in NMR is higher than that used for AFM experiments,
it is unlikely that such an increase in the concentration of the
peptide would change the lipid-peptide interactions from the
model in Fig. 7 C to that in Fig. 7 B. Therefore, it is most
likely the peptide is causing membrane-thinning, which could
be a crucial step in its antimicrobial activity.
CONCLUSIONS
The process of membrane thinning due to antimicrobial
peptide binding has been observed for the ﬁrst time using
AFM. The data shows that the interaction of MSI-78 with
supported DMPC bilayers on mica leads to the formation of
domains of decreased bilayer thickness. As more and more
peptide binds to the membrane, the area covered by those
domains grows, whereas their thickness remains constant.
NMR data is used to conﬁrm that a-helical peptide segments
interact with the lipid headgroup region and disorder the
hydrophobic core of the lipid bilayer. This results in a greater
distance between headgroups and increased mobility of the
acyl chains. The experimental data is consistent with a model
for the membrane-thinning effect of antimicrobial peptides
oriented parallel to the membrane.
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